Drug Discovery Chemistry is the leading conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to move between concurrent meetings and create a unique program according to personal interests. New this year is Epigenetic Inhibitor Discovery which nicely complements the most popular topics from previous years: Anti-Inflammatories, Protein-Protein Interactions, Macrocyclics and Constrained Peptides, Fragment-Based Drug Discovery, and Kinase Inhibitor Chemistry.

• American Peptide Company, Inc.
• AMRI
• ASINEX
• Chemical Computing Group
• Knobbe Martens Olson & Bear LLP
• PharmaCore, Inc.
• SensiQ Technologies
• Synthonix, Inc.